RYGENRUS
stem cells for scientific and medical research; stem cells for medical or clinical use; pharmaceutical compositions comprising stem cells; pharmaceutical compositions comprising stem cells for the treatment of neurological, cardiovascular, inflammatory and immune diseases, critical care disorders, conditions and injuries, solid organ transplantation, wound healing and orthopedics
Abandoned · September 5, 2019 · 88605660 ·
